The diagnosis and treatment of soft tissue sarcomas of the limbs;Diagnostik und therapie von weichteilsarkomen der extremitäten

Deutsches Arzteblatt

Volumn 108, Issue 3, 2011, Pages

  Bannasch, Holger ^a   Eisenhardt, Steffen U ^a   Grosu, Anca Ligia ^a   Heinz, Jürgen ^b   Momeni, Arash ^c   Stark, G Björn ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Abteilung Innere Medizin I Hämatologie und Onkologie   (Germany)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ALGORITHM; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; HUMAN; LIMB SALVAGE; LIMB TUMOR; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PLASTIC SURGERY; REVIEW; SOFT TISSUE SARCOMA; TUMOR BIOPSY;

ALGORITHMS; DECISION SUPPORT TECHNIQUES; EXTREMITIES; HUMANS; RECONSTRUCTIVE SURGICAL PROCEDURES; SARCOMA;

EID: 79951864437     PISSN: 00121207     EISSN: 01722107     Source Type: Journal    
DOI: 10.3238/arztebl.2011.0032     Document Type: Review

References (41)

1. Gutierrez JC, Perez EA, Moffat FL, Livingstone AS, Franceschi D, Koniaris LG.: Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients. Ann Surg 2007; 245: 952-8. (Pubitemid 46809297)
2. Steinau HU, Homann HH, Drücke D, Torres A, Soimaru D, Vogt P: Resektionsmethodik und funktionelle Wiederherstellung bei Weichgewebssarkomen der Extremität. Chirurg 2001; 72: 501-13. (Pubitemid 33678649)
3. Lehnhardt M, Daigeler A, Homann HH, et al.: Importance of specialized centers in diagnosis and treatment of extremitiy-soft tissue sarcomas: Review of 603 cases. Chirurg 2009; 80: 341-7.
4. Bannasch H, Haivas I, Momeni A, Stark GB: Oncosurgical and reconstructive concepts in the treatment of soft tissue sarcomas: a retrospective analysis. Arch Orthop Trauma Surg 2009; 129: 43-9.
5. Lahat G, Lazar A, Lev D: Sarcoma epidemiology and etiology: potential environmental and genetic factors. Surg Clin N Am 2008; 88; 451-81. (Pubitemid 351734513)
6. Lahat G, Tuvin D, Wei C, et al.: New perspectives for staging and prognosis in soft tissue sarcomas. Ann Surg Oncol 2008; 15: 2739-48.
7. Deutsche Gesellschaft für Hämatologie und Onkologie; Leitlinien für Weichteilsarkome des Erwachsenen. www.dgho.de/informationen/ leitlinien/solide-tumore
8. Bruns J, Delling G, Henne-Bruns D, Hossfeld DK: Die Biopsie bei Tumoren des muskuloskeletalen Systems. Dtsch Arztebl 2008; 105: 492-7.
9. Johnson CJ, Pynsent PB, Grimer RJ: Clinical features of soft tissue sarcomas. Ann R C Surg E 2001; 83: 203-5. (Pubitemid 32509725)
10. Misra A, Mistry N, Grimer R, Peart F: The management of soft tissue sarcoma. JPRAS 2009; 62: 161-74.
11. Lehnhardt M, Daigeler A, Hauser J, et al.: The value of expert second opinion in diagnosis of soft tissue sarcomas. J Surg Oncol 2008; 97: 40-3.
12. Casali PG, Jost L, Sleijfer S, et al.: Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008; 19(s): ii89-93.
13. Rosenberg SA, Tepper J, Glatstein E et al.: The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 1982; 196: 305-15.
14. Enneking WF, Spanier SS, Goodman MA: A system for the surgical staging of musculosceletal sarcoma. Clin Orthop Relat Res 1980; 153: 106-20. (Pubitemid 11217753)
15. Kaushal A, Citrin D: The role of radiation therapy in the managment of sarcomas. Surg Clin N Am 2008; 88; 629-46. (Pubitemid 351753024)
16. Lichter AS, Lawrence: Recent advances in radiation oncology. N Eng J Med 1995; 332: 371-9.
17. Strander H, Turesson I, Cavallin-Stahl E: A systematic overview of radiation therapy effects in soft tissue sarcomas. Acta Oncologica 2003; 42: 516-31. (Pubitemid 37193841)
18. O'Sullivan B, Davis AM, Turcotte R, et al.: Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 2002: 359: 2235-41. (Pubitemid 34717977)
19. Hohenberger P, Wysocki WM: Neoadjuvant treatment of locally advanced soft tissue sarcoma of the limbs: which treatment to choose? The Oncologist 2008; 13: 175-86
20. DeLaney TF, Spiro IJ, Suit HD, et al.: Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys 2003: 56: 1117-27. (Pubitemid 36794046)
21. Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M: A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 2008; 113: 573-81.
22. Gortzak E, Azzarelli A, Buesa J, et al.: A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma. Eur J Cancer 2001; 37: 1096-103.
23. Gustafson P, Dreinhofer KE, Rydholm A: Soft tissue sarcoma should be treated at a tumor center. A comparison of quality of surgery in 375 patients. Acta Orthop Scand 1994; 65: 47-50.
24. Clasby R, Tilling K, Smith MA, et al.: Variable management of soft tissue sarcoma: regional audit with implications for specialist care. Br J Surg 1997; 84: 1692-6.
25. Ray-Coquard I, Thiesse P, Ranchere-Vince D, et al.: Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas. Ann Oncol 2004; 15: 307-15.
26. Jemal A, Siegel R, Ward E, et al.: Cancer statistics. CA: a cancer journal for clinicians 2008; 58: 71-96.
27. Rydholm A: Improving the management of soft tissue sarcoma. Diagnosis and treatment should be given in specialist centres. BMJ 1998; 317: 93-4.
28. Gustafson P: Soft tissue sarcoma. Epidemiology and prognosis in 508 patients. Acta Orthop Scand 1994; 259: 1-31.
29. Noria S, Davis AM, Kandel R, et al.: Residual disease following unplanned excision of soft-tissue sarcoma of an extremity. JBJS 1996; 78: 650-5.
30. Davis AM, Kandel R, Wunder JS, et al.: The impact of residual disease on local recurrence in patients treated by initial unplanned resection for soft tissue sarcoma of the extremity. J Surg Oncol 1997; 66: 81-7.
31. Goodlad JR, Fletcher CD and Smith MA: Surgical resection of primary soft-tissue sarcoma. Incidence of residual tumour in 95 patients needing re-excision after local resection. JBJS (Br) 1996; 78: 658-61.
32. Grimer RJ: Size matters for sarcomas! Ann R Coll Surg Engl 2006; 88: 519-24.
33. Berger F, Winkler EC, Ruderer C, et al.: Moderne bildgebende Diagnostik bei Weichteilsarkomen. Chirurg 2009; 80: 175-85.
34. Domanski HA: Fine-needle aspiration cytology of soft tissue lesions: diagnostic challenges. Diagn Cytopathol 2007; 35: 768-73.
35. Singer S, Demetri GD, Baldini EH, et al.: Management of soft-tissue sarcomas: an overview and update. Lancet Oncol 2000; 1: 75-85.
36. Dadia S and Grimer R: Characteristics, diagnosis and treatment of bone and soft tissue sarcomas. Br J Hosp Med 2007; 68: 589-93.
37. Van de Luijtgaarden AC, De Rooy JW, De Geus-Oei LF, et al.: Promises and challenges of positron emission tomography for assesment of sarcoma in daily clinical practice. Cancer Imaging 2008; 8(s): 61-8.
38. Clark MA, Fisher C, Judson I, et al.: Soft-tissue sarcomas in adults. N Eng J Med 2005; 353: 701-11.
39. Doi K, Kuwata N, Kawakami F, et al.: Limb sparing surgery with reinnervated free-muscle transfer following radical excision of soft-tissue sarcoma. Plast Recon Surg 2007; 120: 960-9.
40. Geddes CR, Morris SF, Neligan PC: Perforator flaps: evolution, classification, and applications. Ann Plast Surg 2003; 50: 90-9.
41. O'Sullivan B, Davis AM, Turcotte R, et al.: Five-year results of a randomized phase III trial of pre-operative vs. post-operative radiotherapy in extremity soft tissue sarcoma. Proc Am Soc Clin Oncol 2004; 23: 815a.